Wikipedia -WSS

Wikipedia

author：explore 2025-10-02 11:09:02 - browse：24

A gene therapy study, halted when four children with a rare neuromuscular disorder died after treatment, showed enough promise to merit finding a path forward, according to the medicine’s manufacturer.

The treatment, made by the Japanese pharmaceutical company Astellas, led to severe and fatal liver problems for four of the 24 treated children with X-linked myotubular myopathy, or XLMTM, a genetic disease that severely degrades muscle function and kills most patients before the age of 10. Three died in 2020; the fourth died a year later.

In an analysis of its clinical trial, published in Lancet Neurology on Wednesday, Astellas observed dramatic benefits in the study’s surviving patients and a potential explanation for the deaths that derailed the trial. The hope, for Astellas and for families affected by XLMTM, is that the company can find a safe way to proceed and convince the Food and Drug Administration to allow it to resume development.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Can medical device makers keep up in the race to treat obesity?

WSS

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Timeline: Key moments in fight for gay rights

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Mom launches Girl Scout troop for LGBTQ youth in Texas

Chinese researcher claims birth of first gene

Novo pauses ads for weight loss drug Wegovy amid demand

entertainment

Wikipedia

Wikipedia

Jerome Adams on the need for new antivirals for Covid

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

New air purifier tech could be key to improving indoor air quality

Adam's Take: Intra

Virginia high school admissions case could be legal follow

Biden administration plans revamp of organ transplant system

Activists slam private health insurers over coverage restrictions

Inside the rise of 'mukbang' eating videos

Medicare details structure of new drug price negotiation program

Millions may soon lose Medicaid when they don't have to

hotspot

Novo pauses ads for weight loss drug Wegovy amid demand

CRISPR technology availability, affordability needs to be expanded

Living organ donors deserve priority status for transplants

Biden administration plans revamp of organ transplant system

Erich Jarvis studies song birds to learn about human stuttering

Novo: Oral version of Ozempic leads to 15% weight loss

leisure time

entertainment

focus

hotspot